Onyx Pharmaceuticals is based out of South San Francisco. ONYX Pharmaceuticals Inc discovers and develops novel cancer therapies and has proprietary technologies that target the molecular basis of cancer. The company's lead drug candidate, sorafenib, is in Phase III clinical development.Whalewisdom has at least 175 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
ONYX PHARMACEUTICALS INC249 E. GRAND AVE.
SOUTH SAN FRANCISCO CA 94080
Business Phone: 650-266-0000
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)